mydecine Archives | Psychedelic Spotlight

Tag Archive for: mydecine

Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses

The psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?

Psychedelic Stocks Compass Small Pharma Mydecine Awakn

A Big Week for Psychedelic Stocks: 2 CEOs Step Down, MDMA Patents and a Phase 3 Trial

Business, Stock Reports

Compass Pathways and Small Pharma announce executive shakeup, Mydecine and Awakn push forward with new research

Psychedelic Business News Spotlight - December 24

Psychedelic Business Spotlight – December 24

Business, Stock Reports

This week in psychedelic business news: FDA green lights a new psilocybin study; MindMed commences LSD treatment for ADHD; Sage Institute shuffles leadership.